Skip to main content
$109.03 -$3.30 (-2.9%)

04:00 PM EST on 02/26/21

BioNTech SE (NASDAQ:BNTX)

CAPS Rating: 4 out of 5

Current Price $109.03 Mkt Cap $26.3B
Open $113.90 P/E Ratio 0.00
Prev. Close $109.03 Div. (Yield) $0.00 (0.0%)
Daily Range $109.03 - $114.98 Volume 1,028,633
52-Wk Range $28.00 - $131.00 Avg. Daily Vol. 2,268,070

Caps

How do you think NASDAQ:BNTX will perform against the market?

Add Stock to CAPS Watchlist

All Players

32 Outperform
1 Underperform
 

All-Star Players

10 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:BNTX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

marekz (91.86)
Submitted October 07, 2020

BioNTech has become a clear leader in messenger RNA (mRNA) technology The rapid progress of it's COVID-19 vaccine candidates shows how effective they are, and the limits could boom after any success with COVID. A partnership with Pfeizer in exploding… More

TMFang4apples (78.55)
Submitted December 01, 2020

Great company, but there's no way co-commercialization of bnt162 is going to support a $30 billion valuation once attention for mRNA fizzles. I still haven't seen any sign from mRNA developers that they've found a way to ensure safe long-term dosing,… More

NASDAQ:BNTX VS S&P 500 (SPY)

NASDAQ:BNTX Summary

Fools bullish on NASDAQ:BNTX are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about BNTX.

Recs

0
Member Avatar nyncfl (< 20) Submitted: 2/22/2021 6:04:13 PM : Outperform Start Price: $110.78 NASDAQ:BNTX Score: -0.46

Updates concerning the vaccine continue to improve giving the company additional strength in the industry. The next few months will be exciting given the information continues to be positive. Not to shabby with a 15 B $ income this year

Recs

0
Member Avatar TMFjbonefish (61.14) Submitted: 12/16/2020 6:48:14 PM : Outperform Start Price: $102.64 NASDAQ:BNTX Score: +3.97

I am as excited about the company's other programs for genetically-personalized medicine as I am the COVID vaccine. I think BioNTech is under appreciated as a potential multi-bagger.

Recs

1
Member Avatar TMFang4apples (78.55) Submitted: 12/1/2020 8:51:32 AM : Underperform Start Price: $124.50 NASDAQ:BNTX Score: +16.47

Great company, but there's no way co-commercialization of bnt162 is going to support a $30 billion valuation once attention for mRNA fizzles. I still haven't seen any sign from mRNA developers that they've found a way to ensure safe long-term dosing, a feature shared by like 95% of top-selling drugs. Lots of incoming competition means BNT162 is highly unlikely to become the next Prevnar 13.

Leaderboard

Find the members with the highest scoring picks in BNTX.

Score Leader

TMFSpeyside

TMFSpeyside (90.73) Score: +97.24

The Score Leader is the player with the highest score across all their picks in BNTX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
TMFSpeyside 90.73 6/12/2020 Outperform 5Y $49.37 +120.84% +23.60% +97.24 0 Comment
TMFFishBiz 71.74 6/24/2020 Outperform 1Y $53.83 +102.56% +24.08% +78.48 0 Comment
MonkDayTrade < 20 7/16/2020 Outperform 5Y $63.27 +72.32% +18.94% +53.38 0 Comment
Skippynicki 48.58 9/18/2020 Outperform 5Y $67.53 +61.45% +13.73% +47.73 0 Comment
skiener4 73.64 8/27/2020 Outperform 5Y $70.00 +55.76% +9.14% +46.62 0 Comment
PLAZMASTOX 27.65 6/29/2020 Outperform 5Y $65.68 +66.00% +26.17% +39.83 0 Comment
Blondie442 81.00 6/30/2020 Outperform 5Y $67.83 +60.75% +24.15% +36.59 0 Comment
BHR 46.82 12/29/2020 Outperform 5Y $84.45 +29.11% +1.75% +27.35 0 Comment
Dananator 55.68 8/6/2020 Outperform 5Y $77.20 +41.23% +13.89% +27.34 0 Comment
MikeTheShark1 63.22 1/4/2021 Outperform 5Y $85.45 +27.59% +1.35% +26.25 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BNTX.